Latigo Biotherapeutics, Inc. Common Stock (LTGO) is a publicly traded the market company. As of August 10, 2026, LTGO trades at $18.65 with a market cap of $0 and a P/E ratio of 0.00. LTGO moved +0.99% today. Year to date, LTGO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces LTGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Latigo Biotherapeutics, Inc. Common Stock (LTGO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LTGO moved +0.99% today.
| Metric | Value |
|---|---|
| Price | $18.65 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 565.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
LTGO analyst coverage data. Average price target: $0.00.